Global Bronchiectasis Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026


  • Mar 2021
  • |
  • 156
  • |
  • Pharmaceuticals and Healthcare

The Bronchiectasis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Bronchiectasis Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Bronchiectasis Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Bronchiectasis Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Antibiotics

Expectorants

Other drugs

Market segment by Application, can be divided into

Hospital

Research institute

Clinic

Other

Market segment by players, this report covers

Endo International Plc

GlaxoSmithKline Plc

Neopharma LLC

Pfizer Inc.

Reckitt Benckiser Group Plc

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Bronchiectasis Drugs

1.2 Classification of Bronchiectasis Drugs by Type

1.2.1 Overview: Global Bronchiectasis Drugs Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Bronchiectasis Drugs Revenue Market Share by Type in 2020

1.2.3 Antibiotics

1.2.4 Expectorants

1.2.5 Other drugs

1.3 Global Bronchiectasis Drugs Market by Application

1.3.1 Overview: Global Bronchiectasis Drugs Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Research institute

1.3.4 Clinic

1.3.5 Other

1.4 Global Bronchiectasis Drugs Market Size & Forecast

1.5 Global Bronchiectasis Drugs Market Size and Forecast by Region

1.5.1 Global Bronchiectasis Drugs Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Bronchiectasis Drugs Market Size by Region, (2016-2021)

1.5.3 North America Bronchiectasis Drugs Market Size and Prospect (2016-2026)

1.5.4 Europe Bronchiectasis Drugs Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Bronchiectasis Drugs Market Size and Prospect (2016-2026)

1.5.6 South America Bronchiectasis Drugs Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Bronchiectasis Drugs Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Bronchiectasis Drugs Market Drivers

1.6.2 Bronchiectasis Drugs Market Restraints

1.6.3 Bronchiectasis Drugs Trends Analysis

2 Company Profiles

2.1 Endo International Plc

2.1.1 Endo International Plc Details

2.1.2 Endo International Plc Major Business

2.1.3 Endo International Plc Bronchiectasis Drugs Product and Solutions

2.1.4 Endo International Plc Bronchiectasis Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Endo International Plc Recent Developments and Future Plans

2.2 GlaxoSmithKline Plc

2.2.1 GlaxoSmithKline Plc Details

2.2.2 GlaxoSmithKline Plc Major Business

2.2.3 GlaxoSmithKline Plc Bronchiectasis Drugs Product and Solutions

2.2.4 GlaxoSmithKline Plc Bronchiectasis Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 GlaxoSmithKline Plc Recent Developments and Future Plans

2.3 Neopharma LLC

2.3.1 Neopharma LLC Details

2.3.2 Neopharma LLC Major Business

2.3.3 Neopharma LLC Bronchiectasis Drugs Product and Solutions

2.3.4 Neopharma LLC Bronchiectasis Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Neopharma LLC Recent Developments and Future Plans

2.4 Pfizer Inc.

2.4.1 Pfizer Inc. Details

2.4.2 Pfizer Inc. Major Business

2.4.3 Pfizer Inc. Bronchiectasis Drugs Product and Solutions

2.4.4 Pfizer Inc. Bronchiectasis Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Pfizer Inc. Recent Developments and Future Plans

2.5 Reckitt Benckiser Group Plc

2.5.1 Reckitt Benckiser Group Plc Details

2.5.2 Reckitt Benckiser Group Plc Major Business

2.5.3 Reckitt Benckiser Group Plc Bronchiectasis Drugs Product and Solutions

2.5.4 Reckitt Benckiser Group Plc Bronchiectasis Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Reckitt Benckiser Group Plc Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Bronchiectasis Drugs Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Bronchiectasis Drugs Players Market Share

3.2.2 Top 10 Bronchiectasis Drugs Players Market Share

3.2.3 Market Competition Trend

3.3 Bronchiectasis Drugs Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Bronchiectasis Drugs Revenue and Market Share by Type (2016-2021)

4.2 Global Bronchiectasis Drugs Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Bronchiectasis Drugs Revenue Market Share by Application (2016-2021)

5.2 Bronchiectasis Drugs Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Bronchiectasis Drugs Revenue by Type (2016-2026)

6.2 North America Bronchiectasis Drugs Revenue by Application (2016-2026)

6.3 North America Bronchiectasis Drugs Market Size by Country

6.3.1 North America Bronchiectasis Drugs Revenue by Country (2016-2026)

6.3.2 United States Bronchiectasis Drugs Market Size and Forecast (2016-2026)

6.3.3 Canada Bronchiectasis Drugs Market Size and Forecast (2016-2026)

6.3.4 Mexico Bronchiectasis Drugs Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Bronchiectasis Drugs Revenue by Type (2016-2026)

7.2 Europe Bronchiectasis Drugs Revenue by Application (2016-2026)

7.3 Europe Bronchiectasis Drugs Market Size by Country

7.3.1 Europe Bronchiectasis Drugs Revenue by Country (2016-2026)

7.3.2 Germany Bronchiectasis Drugs Market Size and Forecast (2016-2026)

7.3.3 France Bronchiectasis Drugs Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Bronchiectasis Drugs Market Size and Forecast (2016-2026)

7.3.5 Russia Bronchiectasis Drugs Market Size and Forecast (2016-2026)

7.3.6 Italy Bronchiectasis Drugs Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Bronchiectasis Drugs Revenue by Type (2016-2026)

8.2 Asia-Pacific Bronchiectasis Drugs Revenue by Application (2016-2026)

8.3 Asia-Pacific Bronchiectasis Drugs Market Size by Region

8.3.1 Asia-Pacific Bronchiectasis Drugs Revenue by Region (2016-2026)

8.3.2 China Bronchiectasis Drugs Market Size and Forecast (2016-2026)

8.3.3 Japan Bronchiectasis Drugs Market Size and Forecast (2016-2026)

8.3.4 South Korea Bronchiectasis Drugs Market Size and Forecast (2016-2026)

8.3.5 India Bronchiectasis Drugs Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Bronchiectasis Drugs Market Size and Forecast (2016-2026)

8.3.7 Australia Bronchiectasis Drugs Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Bronchiectasis Drugs Revenue by Type (2016-2026)

9.2 South America Bronchiectasis Drugs Revenue by Application (2016-2026)

9.3 South America Bronchiectasis Drugs Market Size by Country

9.3.1 South America Bronchiectasis Drugs Revenue by Country (2016-2026)

9.3.2 Brazil Bronchiectasis Drugs Market Size and Forecast (2016-2026)

9.3.3 Argentina Bronchiectasis Drugs Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Bronchiectasis Drugs Revenue by Type (2016-2026)

10.2 Middle East & Africa Bronchiectasis Drugs Revenue by Application (2016-2026)

10.3 Middle East & Africa Bronchiectasis Drugs Market Size by Country

10.3.1 Middle East & Africa Bronchiectasis Drugs Revenue by Country (2016-2026)

10.3.2 Turkey Bronchiectasis Drugs Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Bronchiectasis Drugs Market Size and Forecast (2016-2026)

10.3.4 UAE Bronchiectasis Drugs Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Bronchiectasis Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Bronchiectasis Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Bronchiectasis Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Bronchiectasis Drugs Revenue (USD Million) by Region (2016-2021)

Table 5. Global Bronchiectasis Drugs Revenue Market Share by Region (2021-2026)

Table 6. Endo International Plc Corporate Information, Head Office, and Major Competitors

Table 7. Endo International Plc Major Business

Table 8. Endo International Plc Bronchiectasis Drugs Product and Solutions

Table 9. Endo International Plc Bronchiectasis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. GlaxoSmithKline Plc Corporate Information, Head Office, and Major Competitors

Table 11. GlaxoSmithKline Plc Major Business

Table 12. GlaxoSmithKline Plc Bronchiectasis Drugs Product and Solutions

Table 13. GlaxoSmithKline Plc Bronchiectasis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Neopharma LLC Corporate Information, Head Office, and Major Competitors

Table 15. Neopharma LLC Major Business

Table 16. Neopharma LLC Bronchiectasis Drugs Product and Solutions

Table 17. Neopharma LLC Bronchiectasis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Pfizer Inc. Corporate Information, Head Office, and Major Competitors

Table 19. Pfizer Inc. Major Business

Table 20. Pfizer Inc. Bronchiectasis Drugs Product and Solutions

Table 21. Pfizer Inc. Bronchiectasis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Reckitt Benckiser Group Plc Corporate Information, Head Office, and Major Competitors

Table 23. Reckitt Benckiser Group Plc Major Business

Table 24. Reckitt Benckiser Group Plc Bronchiectasis Drugs Product and Solutions

Table 25. Reckitt Benckiser Group Plc Bronchiectasis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Global Bronchiectasis Drugs Revenue (USD Million) by Players (2019-2021)

Table 27. Global Bronchiectasis Drugs Revenue Share by Players (2019-2021)

Table 28. Breakdown of Bronchiectasis Drugs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 29. Bronchiectasis Drugs Players Head Office, Products and Services Provided

Table 30. Bronchiectasis Drugs Mergers & Acquisitions in the Past Five Years

Table 31. Bronchiectasis Drugs New Entrants and Expansion Plans

Table 32. Global Bronchiectasis Drugs Revenue (USD Million) by Type (2016-2021)

Table 33. Global Bronchiectasis Drugs Revenue Share by Type (2016-2021)

Table 34. Global Bronchiectasis Drugs Revenue Forecast by Type (2021-2026)

Table 35. Global Bronchiectasis Drugs Revenue by Application (2016-2021)

Table 36. Global Bronchiectasis Drugs Revenue Forecast by Application (2021-2026)

Table 37. North America Bronchiectasis Drugs Revenue by Type (2016-2021) & (USD Million)

Table 38. North America Bronchiectasis Drugs Revenue by Type (2021-2026) & (USD Million)

Table 39. North America Bronchiectasis Drugs Revenue by Application (2016-2021) & (USD Million)

Table 40. North America Bronchiectasis Drugs Revenue by Application (2021-2026) & (USD Million)

Table 41. North America Bronchiectasis Drugs Revenue by Country (2016-2021) & (USD Million)

Table 42. North America Bronchiectasis Drugs Revenue by Country (2021-2026) & (USD Million)

Table 43. Europe Bronchiectasis Drugs Revenue by Type (2016-2021) & (USD Million)

Table 44. Europe Bronchiectasis Drugs Revenue by Type (2021-2026) & (USD Million)

Table 45. Europe Bronchiectasis Drugs Revenue by Application (2016-2021) & (USD Million)

Table 46. Europe Bronchiectasis Drugs Revenue by Application (2021-2026) & (USD Million)

Table 47. Europe Bronchiectasis Drugs Revenue by Country (2016-2021) & (USD Million)

Table 48. Europe Bronchiectasis Drugs Revenue by Country (2021-2026) & (USD Million)

Table 49. Asia-Pacific Bronchiectasis Drugs Revenue by Type (2016-2021) & (USD Million)

Table 50. Asia-Pacific Bronchiectasis Drugs Revenue by Type (2021-2026) & (USD Million)

Table 51. Asia-Pacific Bronchiectasis Drugs Revenue by Application (2016-2021) & (USD Million)

Table 52. Asia-Pacific Bronchiectasis Drugs Revenue by Application (2021-2026) & (USD Million)

Table 53. Asia-Pacific Bronchiectasis Drugs Revenue by Region (2016-2021) & (USD Million)

Table 54. Asia-Pacific Bronchiectasis Drugs Revenue by Region (2021-2026) & (USD Million)

Table 55. South America Bronchiectasis Drugs Revenue by Type (2016-2021) & (USD Million)

Table 56. South America Bronchiectasis Drugs Revenue by Type (2021-2026) & (USD Million)

Table 57. South America Bronchiectasis Drugs Revenue by Application (2016-2021) & (USD Million)

Table 58. South America Bronchiectasis Drugs Revenue by Application (2021-2026) & (USD Million)

Table 59. South America Bronchiectasis Drugs Revenue by Country (2016-2021) & (USD Million)

Table 60. South America Bronchiectasis Drugs Revenue by Country (2021-2026) & (USD Million)

Table 61. Middle East & Africa Bronchiectasis Drugs Revenue by Type (2016-2021) & (USD Million)

Table 62. Middle East & Africa Bronchiectasis Drugs Revenue by Type (2021-2026) & (USD Million)

Table 63. Middle East & Africa Bronchiectasis Drugs Revenue by Application (2016-2021) & (USD Million)

Table 64. Middle East & Africa Bronchiectasis Drugs Revenue by Application (2021-2026) & (USD Million)

Table 65. Middle East & Africa Bronchiectasis Drugs Revenue by Country (2016-2021) & (USD Million)

Table 66. Middle East & Africa Bronchiectasis Drugs Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Bronchiectasis Drugs Picture

Figure 2. Global Bronchiectasis Drugs Revenue Market Share by Type in 2020

Figure 3. Antibiotics

Figure 4. Expectorants

Figure 5. Other drugs

Figure 6. Bronchiectasis Drugs Revenue Market Share by Application in 2020

Figure 7. Hospital Picture

Figure 8. Research institute Picture

Figure 9. Clinic Picture

Figure 10. Other Picture

Figure 11. Global Bronchiectasis Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Bronchiectasis Drugs Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Bronchiectasis Drugs Revenue Market Share by Region (2016-2026)

Figure 14. Global Bronchiectasis Drugs Revenue Market Share by Region in 2020

Figure 15. North America Bronchiectasis Drugs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Bronchiectasis Drugs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Bronchiectasis Drugs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Bronchiectasis Drugs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Bronchiectasis Drugs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Bronchiectasis Drugs Market Drivers

Figure 21. Bronchiectasis Drugs Market Restraints

Figure 22. Bronchiectasis Drugs Market Trends

Figure 23. Endo International Plc Recent Developments and Future Plans

Figure 24. GlaxoSmithKline Plc Recent Developments and Future Plans

Figure 25. Neopharma LLC Recent Developments and Future Plans

Figure 26. Pfizer Inc. Recent Developments and Future Plans

Figure 27. Reckitt Benckiser Group Plc Recent Developments and Future Plans

Figure 28. Global Bronchiectasis Drugs Revenue Share by Players in 2020

Figure 29. Bronchiectasis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 30. Global Top 3 Players Bronchiectasis Drugs Revenue Market Share in 2020

Figure 31. Global Top 10 Players Bronchiectasis Drugs Revenue Market Share in 2020

Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 33. Global Bronchiectasis Drugs Revenue Share by Type in 2020

Figure 34. Global Bronchiectasis Drugs Market Share Forecast by Type (2021-2026)

Figure 35. Global Bronchiectasis Drugs Revenue Share by Application in 2020

Figure 36. Global Bronchiectasis Drugs Market Share Forecast by Application (2021-2026)

Figure 37. North America Bronchiectasis Drugs Sales Market Share by Type (2016-2026)

Figure 38. North America Bronchiectasis Drugs Sales Market Share by Application (2016-2026)

Figure 39. North America Bronchiectasis Drugs Revenue Market Share by Country (2016-2026)

Figure 40. United States Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Bronchiectasis Drugs Sales Market Share by Type (2016-2026)

Figure 44. Europe Bronchiectasis Drugs Sales Market Share by Application (2016-2026)

Figure 45. Europe Bronchiectasis Drugs Revenue Market Share by Country (2016-2026)

Figure 46. Germany Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. France Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. United Kingdom Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Russia Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Italy Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Asia-Pacific Bronchiectasis Drugs Sales Market Share by Type (2016-2026)

Figure 52. Asia-Pacific Bronchiectasis Drugs Sales Market Share by Application (2016-2026)

Figure 53. Asia-Pacific Bronchiectasis Drugs Revenue Market Share by Region (2016-2026)

Figure 54. China Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Japan Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. South Korea Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. India Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Southeast Asia Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Australia Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. South America Bronchiectasis Drugs Sales Market Share by Type (2016-2026)

Figure 61. South America Bronchiectasis Drugs Sales Market Share by Application (2016-2026)

Figure 62. South America Bronchiectasis Drugs Revenue Market Share by Country (2016-2026)

Figure 63. Brazil Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Argentina Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Middle East and Africa Bronchiectasis Drugs Sales Market Share by Type (2016-2026)

Figure 66. Middle East and Africa Bronchiectasis Drugs Sales Market Share by Application (2016-2026)

Figure 67. Middle East and Africa Bronchiectasis Drugs Revenue Market Share by Country (2016-2026)

Figure 68. Turkey Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Saudi Arabia Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. UAE Bronchiectasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Methodology

Figure 72. Research Process and Data Source

Sample Request is not available